These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 19853660)

  • 21. Coexpression of acidic fibroblast growth factor enhances specific productivity and antibody titers in transiently transfected HEK293 cells.
    Backliwal G; Hildinger M; Chenuet S; Dejesus M; Wurm FM
    N Biotechnol; 2008; 25(2-3):162-6. PubMed ID: 18804191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In pursuit of the optimal fed-batch process for monoclonal antibody production.
    Bibila TA; Robinson DK
    Biotechnol Prog; 1995; 11(1):1-13. PubMed ID: 7765983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heuristic optimization of antibody production by Chinese hamster ovary cells.
    Sandadi S; Ensari S; Kearns B
    Biotechnol Prog; 2005; 21(5):1537-42. PubMed ID: 16209559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implementation of advanced technologies in commercial monoclonal antibody production.
    Zhou JX; Tressel T; Yang X; Seewoester T
    Biotechnol J; 2008 Oct; 3(9-10):1185-200. PubMed ID: 18759247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suspension culture of mammalian cells.
    Birch JR; Arathoon R
    Bioprocess Technol; 1990; 10():251-70. PubMed ID: 1367062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transient gene expression in HEK293 cells: peptone addition posttransfection improves recombinant protein synthesis.
    Pham PL; Perret S; Cass B; Carpentier E; St-Laurent G; Bisson L; Kamen A; Durocher Y
    Biotechnol Bioeng; 2005 May; 90(3):332-44. PubMed ID: 15803471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of cell culture process changes on endogenous retrovirus expression.
    Brorson K; De Wit C; Hamilton E; Mustafa M; Swann PG; Kiss R; Taticek R; Polastri G; Stein KE; Xu Y
    Biotechnol Bioeng; 2002 Nov; 80(3):257-67. PubMed ID: 12226857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dependence on glucose limitation of the pCO2 influences on CHO cell growth, metabolism and IgG production.
    Takuma S; Hirashima C; Piret JM
    Biotechnol Bioeng; 2007 Aug; 97(6):1479-88. PubMed ID: 17318909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances in large-scale production of monoclonal antibodies and related proteins.
    Shukla AA; Thömmes J
    Trends Biotechnol; 2010 May; 28(5):253-61. PubMed ID: 20304511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conversion of a CHO cell culture process from perfusion to fed-batch technology without altering product quality.
    Meuwly F; Weber U; Ziegler T; Gervais A; Mastrangeli R; Crisci C; Rossi M; Bernard A; von Stockar U; Kadouri A
    J Biotechnol; 2006 May; 123(1):106-16. PubMed ID: 16324762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving performance of mammalian cells in fed-batch processes through "bioreactor evolution".
    Prentice HL; Ehrenfels BN; Sisk WP
    Biotechnol Prog; 2007; 23(2):458-64. PubMed ID: 17311405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal antibody: high density culture of hybridoma cells and downstream processing for IgG recovery.
    Kundu PK; Prasad NS; Datta D
    Indian J Exp Biol; 1998 Feb; 36(2):125-35. PubMed ID: 9754040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of hyperosmotic pressure on antibody production and gene expression in the GS-NS0 cell line.
    Wu MH; Dimopoulos G; Mantalaris A; Varley J
    Biotechnol Appl Biochem; 2004 Aug; 40(Pt 1):41-6. PubMed ID: 15270706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioreactor technology: a novel industrial tool for high-tech production of bioactive molecules and biopharmaceuticals from plant roots.
    Sivakumar G
    Biotechnol J; 2006 Dec; 1(12):1419-27. PubMed ID: 17136730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal construction of non-immune scFv phage display libraries from mouse bone marrow and spleen established to select specific scFvs efficiently binding to antigen.
    Okamoto T; Mukai Y; Yoshioka Y; Shibata H; Kawamura M; Yamamoto Y; Nakagawa S; Kamada H; Hayakawa T; Mayumi T; Tsutsumi Y
    Biochem Biophys Res Commun; 2004 Oct; 323(2):583-91. PubMed ID: 15369791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microarray-based gene expression analysis as a process characterization tool to establish comparability of complex biological products: scale-up of a whole-cell immunotherapy product.
    Wang M; Senger RS; Paredes C; Banik GG; Lin A; Papoutsakis ET
    Biotechnol Bioeng; 2009 Nov; 104(4):796-808. PubMed ID: 19591186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Process parameter shifting: Part II. Biphasic cultivation-A tool for enhancing the volumetric productivity of batch processes using Epo-Fc expressing CHO cells.
    Trummer E; Fauland K; Seidinger S; Schriebl K; Lattenmayer C; Kunert R; Vorauer-Uhl K; Weik R; Borth N; Katinger H; Müller D
    Biotechnol Bioeng; 2006 Aug; 94(6):1045-52. PubMed ID: 16736532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemical caspase inhibitors enhance cell culture viabilities and protein titer.
    Arden N; Ahn SH; Vaz W; Rhodes M; Hancock C; Abitorabi MA; Betenbaugh MJ
    Biotechnol Prog; 2007; 23(2):506-11. PubMed ID: 17381129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microwell engineering characterization for mammalian cell culture process development.
    Barrett TA; Wu A; Zhang H; Levy MS; Lye GJ
    Biotechnol Bioeng; 2010 Feb; 105(2):260-75. PubMed ID: 19739083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Achievement of high cell density and high antibody productivity by a controlled-fed perfusion bioreactor process.
    Yang JD; Angelillo Y; Chaudhry M; Goldenberg C; Goldenberg DM
    Biotechnol Bioeng; 2000 Jul; 69(1):74-82. PubMed ID: 10820333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.